ADMA Biologics

5800 Park of Commerce Blvd. NW
Boca Raton, FL 33487
United States

Tel: 201-478-5222
Fax: 201-478-5553

About ADMA Biologics

ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.

174 articles about ADMA Biologics

ADMA Biologics, Inc. To Present At The Oppenheimer 24th Annual Healthcare Conference

12/2/2013
ADMA Biologics, Inc. Reports Third Quarter 2013 Financial And Operational Results

11/13/2013
ADMA Biologics, Inc. Completes Enrollment of Phase 3 Study for RI-002

11/4/2013
RSV Vaccines for the World 2013 Conference Presentation Highlights Data from ADMA Biologics, Inc.’ Human and Animal Study Experience

10/29/2013
ADMA Biologics, Inc. Announces Closing of Initial Public Offering

10/23/2013
ADMA Biologics, Inc. Announces Pricing of Initial Public Offering

10/17/2013
ADMA Biologics, Inc. Reports Second Quarter 2013 Financial and Operational Results

8/13/2013
ADMA Biologics, Inc.’s Plasma Collection Facility Receives GHA Certification for the Sale of Source Plasma in Europe

6/18/2013
ADMA Biologics, Inc. Reports First Quarter 2013 Financial and Operational Results

5/15/2013
ADMA Biologics, Inc. Reports 2012 Year End Financial and Operational Results

3/7/2013
Biotest Pharmaceuticals Signs Supply, License Pact With ADMA Biologics, Inc.

1/11/2013
ADMA Biologics, Inc. Secures Up to $6 Million Term Loan Commitment to Advance Phase III Study

1/7/2013
ADMA Biologics, Inc. Reports 2012 Third Quarter Results

11/13/2012
ADMA Biologics, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference

9/6/2012

First
Previous
6
7
8
9
Last